Pasithea Therapeutics Corp. (KTTAW) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Miami Beach, FL, United States. The current CEO is Tiago Reis Marques.
KTTAW has IPO date of 2021-09-15, 4 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $110.89K.
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
